Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8286bde48d5077479faf28ad8a98b003 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
1999-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2003-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deee13692a023fedf7a1c892c6a7a8fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d643801206616d6d526969f47313b900 |
publicationDate |
2003-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1018340-B1 |
titleOfInvention |
Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them |
abstract |
The present invention concerns new very stable inclusion compounds from a hydrosoluble basic amino acid salt of a benzimidazole derivative, namely omeprazole, lansoprazole and pantoprazole, and one or more cyclodextrins, preferably beta -cyclodextrin; the process of their preparation, and their use in the manufacture of a medicine for the profilactic and therapeutic treatment of duodenal gastric ulcer, gastro esophageal reflow disease and Zollinger-Ellison-syndrom are also disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7749982-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732404-B2 |
priorityDate |
1999-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |